May 4, 2016
It is usual that pharmaceutical trademarks contain commonly used terms, so they are formed by the combination of elements such as prefixes, suffixes or commonly used words that evoke somehow an idea about the properties of the product, its active principles, and its therapeutic function. They also may refer to a component of the medicine…
Read More
April 20, 2016
The current state of the law on patent-eligibility under 35 U.S.C. § 101 reflects confusion among US courts that is causing harm to patent owners, inventors, and the marketplace. This confusion has persisted throughout the development of the patent-eligibility jurisprudence since the US Supreme Court’s decision in Bilski v. Kappos, 561 U.S. 593 (2010) and, more…
Read More
April 7, 2016
On 23 and 24 December 2015, the EU Council approved a package of reforms to the laws governing trade marks within the European Union. The reforms are anticipated to have wide-reaching consequences for holders of and applicants for trade mark rights within the EU. Many significant changes have already taken effect as from 23 March…
Read More
March 16, 2016
The unitary Community Trade Mark (CTM) was introduced in 1996. Since then there have been no major changes to the system. However, the IP landscape and business environment have changed dramatically leaving Europe’s trade mark system behind. To review and remedy this problem, the European Commission carried out a comprehensive evaluation of the overall functioning…
Read More
March 14, 2016
Introduction If you run a business and have a brand, then the chances are you will want to protect your brand in order to stop others from copying it and potentially stealing your customers. Your brand could be a word, a logo or perhaps a combination of the two. Whatever it is, the best form…
Read More
« Newer EntriesOlder Entries »